Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study. Hwang AS, Kechter JA, Li X, Hughes A, et al. J Invest Dermatol 2024;144:1994-2001.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hwang AS, Kechter JA, Li X, Hughes A, et al. Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study. J Invest Dermatol 2024;144:1994-2001.
PMID: 38417541